43 companies, 1 interpreter! Insight, foresight
and recommendation 

Model Portfolio


RegMed Investors’ model portfolio is designed specifically to allow stem and cell therapy investors to leverage the strategic insights and qualitative and quantitative synthesis that are relied on by institutional, retail and individual investors.  

We track daily and monthly performance and market commentary incorporating quarterly tactical updates with buying and selling insights, plus risk and bench-marking analytics!

As market conditions change, RegMed Investors tactically re-allocates “signals” of the portfolio and provides updates with trading rationale!